Freedom of Information request on the a third-dose booster was evaluated through the COV-Boost trial (FOI 21/1341)
Published 31 May 2022
© Crown copyright 2022
This publication is licensed under the terms of the Open Government Licence v3.0 except where otherwise stated. To view this licence, visit nationalarchives.gov.uk/doc/open-government-licence/version/3 or write to the Information Policy Team, The National Archives, Kew, London TW9 4DU, or email: psi@nationalarchives.gov.uk.
Where we have identified any third party copyright information you will need to obtain permission from the copyright holders concerned.
This publication is available at https://www.gov.uk/government/publications/freedom-of-information-responses-from-the-mhra-week-commencing-20-december-2021/freedom-of-information-request-on-the-a-third-dose-booster-was-evaluated-through-the-cov-boost-trial-foi-211341
FOI 21/1341
24th December 2021
Dear,
The use of the vaccine as a third-dose booster was evaluated through the COV-Boost trial, further information on this trial is provided below.
Kind regards,
MHRA Customer Service Centre
Medicines and Healthcare products Regulatory Agency
10 South Colonnade, Canary Wharf, London E14 4PU
Telephone 020 3080 6000